Report Finds DMARDs Effective in Treating Juvenile Arthritis - Sacramento Bee

Report Finds DMARDs Effective in Treating Juvenile Arthritis Sacramento Bee Juvenile idiopathic arthritis, sometimes called juvenile rheumatoid arthritis, is a common childhood disease that affects up to 400 out of every 100000 children in the United States. Juvenile idiopathic (meaning it has no known cause) arthritis is the ... and more »

Canakinumab Relieves Symptoms In Systemic Juvenile Idiopathic Arthritis - Medical News Today

ThirdAge

Canakinumab Relieves Symptoms In Systemic Juvenile Idiopathic Arthritis Medical News Today Canakinumab (ACZ885; Novartis) achieves major relief of symptoms in patients with systemic juvenile idiopathic arthritis (SJIA), according to encouraging results from a pivotal phase III trial with the anti-interleukin-1 beta antibody reported at the ... Novartis study showed ACZ885 provided substantial symptom relief in 84% of ...Reuters (press release) Novartis announces arthritis drug study resultsBusinessWeek Novartis Announces Potential Treatment For Juvenile ArthritisThirdAge RTT News -Pharma Times -Forbes all 52 news articles »

Las Vegas area foundation focuses on aiding children with arthritis - Las Vegas Review-Journal

Las Vegas area foundation focuses on aiding children with arthritis Las Vegas Review-Journal "It was just after her first birthday we were told it was juvenile rheumatoid arthritis," Janessa Dynabursky said. "We thought 'Oh, just arthritis?' We didn't know how debilitating or how challenging that could be." The Arthritis Foundation estimates ...

Rheumatoid Arthritis Website Launched To Educate Suffers - Online PR News (press release)

Rheumatoid Arthritis Website Launched To Educate Suffers Online PR News (press release) That is not true, as thousands of children from six months to sixteen years of age are afflicted with juvenile rheumatoid arthritis. The web site informs parents of this form of the condition, what rheumatoid arthritis symptoms to look for, ...